MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia

for Associazione Italiana Ricerca Istiocitosi ONLUS, A. Bonometti, G. Ferrario, A. Parafioriti, D. Giardino, F. Simonetti, A. Ginori, E. Passoni, E. Berti

Research output: Contribution to journalArticlepeer-review

Abstract

Mixed histiocytoses are a rare and recently recognized subset of histiocytic disorders that may involve the skin, characterized by the synchronous or metachronous development of lesions with Langerhans and/or non-Langerhans cell histiocytosis histopathological features. Around 10% of patients diagnosed with histiocytosis may develop a hematological malignancy, often with dramatic prognostic consequences. We hereby describe the exceptional case of a patient developing a MAP2K1-driven mixed histiocytosis with Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease, and Erdheim-Chester disease features and cutaneous involvement, progressing to a fatal and clonally-related acute myeloid leukemia. We reviewed the literature on similar cases and discussed the histopathological difficulties in their diagnosis and their clinical-pathological features.

Original languageEnglish
Pages (from-to)637-643
Number of pages7
JournalJournal of Cutaneous Pathology
Volume48
Issue number5
DOIs
Publication statusPublished - 2021

Keywords

  • case report

Fingerprint

Dive into the research topics of 'MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this